SQSTM1 and breast carcinoma: Our patient breast cancer data show that upregulation of p62/SQSTM1 tended to be associated with poor MFS (5-year MFS 54% versus 62%, log-rank test, P=0.088; not shown) in agreement with published work18, 19.